financetom
Business
financetom
/
Business
/
PRESS DIGEST- Financial Times - Sept 10
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
PRESS DIGEST- Financial Times - Sept 10
Sep 11, 2024 5:03 AM

Sept 10 (Reuters) - The following are the top stories in

the Financial Times. Reuters has not verified these stories and

does not vouch for their accuracy.

Headlines

- Elon Musk faces possible summons before UK parliament over

role of X

- PwC to parachute in UK partner to run scandal-hit China

business

- HSBC ( HSBC ) considers cost-cutting merger of commercial and

investment banking units

- Keir Starmer pledges to end attacks on trade union

movement

Overview

- Elon Musk will be asked by the UK parliament to give

evidence about the operations of social media platform X under

plans drawn up by a leading contender to become chair of a key

panel of MPs.

- Auditor PwC is set to parachute in a senior partner from

the UK to run its business in China, as the fallout from its

audit of collapsed property developer Evergrande continues to

mount.

- HSBC's ( HSBC ) top executives have discussed a plan to merge its

commercial and investment banking units, bringing together two

of its three divisions in what would be a significant move by

new chief executive Georges Elhedery to cut costs.

- British Prime Minister Keir Starmer will promise to end

"cheap and vindictive attacks" on the trade union movement as he

promises to work with both businesses and unions to "rewire" the

British economy.

(Compiled by Bengaluru newsroom)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Bayer must pay $78 mln in latest Roundup cancer trial, jury finds
Bayer must pay $78 mln in latest Roundup cancer trial, jury finds
Oct 10, 2024
Oct 10 (Reuters) - Bayer must pay $78 million to a Pennsylvania man who said he got cancer from using the company's Roundup weedkiller, a state court jury in Philadelphia found on Thursday. The verdict in state court in Philadelphia follows previous consecutive victories for Bayer in that court. The company has won 14 of the previous 20 trials over...
Looking At American Express's Recent Unusual Options Activity
Looking At American Express's Recent Unusual Options Activity
Oct 10, 2024
High-rolling investors have positioned themselves bearish on American Express ( AXP ) , and it's important for retail traders to take note. This activity came to our attention today through Benzinga's tracking of publicly available options data. The identities of these investors are uncertain, but such a significant move in AXP often signals that someone has privileged information. Today, Benzinga's...
Teva agrees to pay $450m to resolve kickback allegations, US Justice Dept says
Teva agrees to pay $450m to resolve kickback allegations, US Justice Dept says
Oct 10, 2024
WASHINGTON, Oct 10 (Reuters) - New Jersey-based drugmaker Teva has agreed to pay $450 million to resolve allegations that it violated an anti-kickback statute and the False Claims Act, the U.S. Justice department said in a statement on Thursday. Kickbacks designed to induce referrals or purchases of healthcare goods or services distort physician and patient decision-making, thwart competition and bypass...
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
Oct 10, 2024
Oct 10 (Reuters) - Drug developer Denali Therapeutics ( DNLI ) said on Thursday its partner Sanofi has discontinued a mid-stage study testing their experimental drug to treat multiple sclerosis as it failed to meet the main and secondary goals. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved